Background: Cognitive impairment (CI) is a common manifestation of multiple sclerosis (MS), which can severely affect patients' and their families' life. Early suspicion and detection of CI can improve general medical management of MS patients. Objectives: To correlate MS related CI to cortical brain lesions using brain magnetic resonance imaging (MRI). Materials and Methods: Cognitive impairment was detected using mini mental state examination (MMSE); Neurological examination and brain MRI were performed for all patients. Correlation was calculated between disease cortical burden detected by MRI and CI. Results: Fifty-three patients with proven MS were scanned by brain MRI; 69.8% of them had cognitive impairment diagnosed with MMSE. The presence and severity of cognitive impairment was correlated to cortical brain lesion. Cognitive impairment was not correlated with non-cortical brain lesions or neurological physical disability measured by Expanded Disability Status Scale (EDSS). Conclusions: Presence of brain frontal cortical lesions detected by MRI in MS patients can predict subsequent development of MS-related CI.
Introduction
In 1849, Dr. Friedrich von Frerichs was the primary one to note that multiple sclerosis (MS) isn't exclusively motor dysfunction but moreover ends up in cog-These MS-related CIs are less severe than CI observed in Alzheimer's disease; however, it can severely affect the patients and their family's lives [2] . It mainly leads to occupational disability as more than 50% of MS patients are unemployed within 10 years of diagnosis and this is mainly due to CI rather than to physical disability [3] . Also those patients became socially less active than before which also attributed mainly to MS-related CI [4] . So early detection and diagnosis of CI in MS patients is very important.
MRI is the cornerstone to the initial diagnostic workup of patients suspected to have MS [5] but MRI usually shows CNS lesions of variable sizes, numbers and in different locations among MS patients, moreover brain atrophy correlates moderately with MS-related CI so it can't be used solely to predict CI in MS patients [6] [7] [8] [9] .
Correlating the exact site of the cerebral MS lesions to CI may give us a sight for early detection of CI, which has important implications for managing and compensating for the daily problems that CI may produce, as well as to reveal areas of the brain that might be logical therapeutic targets for management and research. The Objectives of our study is to correlate between the exact site of demyelinating lesions detected by brain MRI and CI in MS patients.
Materials and Methods
After approval from our institutional ethical committee, this study was conducted throughout the amount from August 2016 until December 2018, in line with the rules of 1995 of Helsinki.
A fifty three consecutive patients with confirmed diagnosis of MS according to Polman and his colleagues 2011 [10] who revised neurology outpatient clinics at Mansoura University Hospital, were enrolled in this study, 33 of them were females and 20 were males. A full detailed history taking and complete neurological examination was performed by a specialized neurologist for each patient.
Inclusion criterion was a diagnosis of MS and the patient agree to gave their informed consent to participate in this study this study. Exclusion criteria were patients unfit to perform brain MRI for any reasons as prosthetic heart pacemaker or patients who have a metallic foreign body (metal sliver) in their eye, or who have an aneurysm clip in their brain.
According to disease progression, patients were sub-grouped into; relapsing remitting (RR) [24 patients], primary progressive (PP) [ [11] . Any patient received elicited drugs, steroids or any psychoactive therapy during the last 3 months, that can influence cognitive test outcome of the patient was excluded from this study, also patients with an acute relapsing phase of MS were excluded.
The patients' physical disabilities were assessed by the Expanded Disability Status Scale (EDSS) which ranges from 0 to 10 in 0.5-unit increments (Appendix). It is based on measures of impairment in 8 functional systems (pyramidal, cerebellar, brainstem, sensory, sphincter, visual, mental and other functions). Each functional system is scored on a scale of 0 (no disability) to 5 or 6 (increasing disability). EDSS from 1.0 to 4.5 indicate MS patients who are able to walk without aid; while score 5.0 to 9.5 indicates MS patients with impaired walking [12] .
All patients were radiologically evaluated by brain MRI, The MRI examinations were performed on 1. non-cortical brain MRI abnormality was determined by independent sample t-test. Statistical significance was set at P < 0.05.
Results
Fifty-three patients with proven diagnosis of MS underwent brain MRI to localize the brain demyelinating lesions, 62.3% of them were females (33 patients) and 37.7% were males (20 patients), their ages ranged from18 to 50 years with mean age of 33.81 ± 7.87 years, the mean duration of the disease was 37.75 ± 23.24 months, twenty-four patients were belonging to the relapsing remitting type of MS, 13 patients were primary progressive, 9 were secondary progressive and only 7 were belonging to the clinically isolated syndrome category of MS (Table 1) .
Brain MRI analysis of the cortical lesions revealed that, anatomically brain cortical demyelinating patches mainly located at frontal lobe (106 cortical lesions), followed by temporal lobe (56 cortical lesions), then parietal lobe (23 cortical lesions), then occipital lobe (13 cortical lesions) and lastly cerebellar region (8 cortical lesions); while clinically, brain cortical demyelinating patches mainly affect patients with relapsing remitting MS (108 cortical lesions), followed by patients with primary progressive MS (51 cortical lesions), then patients with secondary progressive MS (32 cortical lesions) and finally patients with clinically isolated syndrome (15 cortical lesions) ( Table 2) . No. = number, SD = standard deviation, MS = multiple sclerosis, RR = relapsing remitting, PR = primary progressive, SP = secondary progressive, CIS = clinically isolated syndrome, EDSS = expanded disability status scale. Journal of Behavioral and Brain Science
When comparing cortical and non-cortical brain demyelinating lesions and correlating them to cognitive impairment it revealed that total burden of demyelinating lesions correlates more with the presence of cognitive impairment rather than the cortical lesions, except in frontal lobe where cortical brain lesions correlates significantly with cognitive impairment when compared with non-cortical brain lesions (Table 3 ) Table 4 showing a correlation between the number of the cortical brain lesions and degree of cognitive impairment, it shows a high statistically significant relationship between the number of cortical brains demyelinating lesions and the degree of CI in different brain region except in the cerebellar region were such correlation didn't exist. No. = number, SD = standard deviation, MRI = magnetic resonant imaging, DIR = double inversion recovery, MS = multiple sclerosis, RR = relapsing remitting, PR = primary progressive, SP = secondary progressive, CIS = clinically isolated syndrome. 
Discussion
Early recognition of MS patients susceptible to develop cognitive impairment for early detection and management of cognitive impairment may improve the total medical care applied to MS patients, so we try to investigate the relation between cognitive impairment and abnormal brain demyelinating lesions detected by brain MRI; and comparing between cortical brain lesions and non-cortical brain lesions in different brain lesion to cognitive impairment.
In this study we find a relationship between cortical brain demyelination le- his colleague as they confirm that brain disease in the frontal lobe related to the degree of cognitive impairment in MS patients [18] .
In our studied MS subgroups, the cortical lesions were more frequent in relapsing remitting MS patients, this may be explained by frequent attacks and longer duration of the disease, in a study conducted by Calabrese et al., the number of cortical lesion associated with CI is more in relapsing remitting MS patients [19] , in contrary to our results; other studies found that progressive MS diseases more vulnerable to cognitive impairment compared to relapsing remitting MS [20] [21] [22] .
Conclusion
This study revealed that cortical brain lesions detected by MRI can be used as marker for subsequent development of cognitive impairment, especially if these cortical brain lesions are detected in the frontal lobe. Journal of Behavioral and Brain Science
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